Impact of Thrombocytopenia on Survival in Patients with Hepatocellular Carcinoma: Updated Meta-Analysis and Systematic Review

被引:1
|
作者
Kraj, Leszek [1 ,2 ]
Chmiel, Paulina [3 ]
Gryziak, Maciej [1 ]
Grabowska-Derlatka, Laretta [4 ]
Szymanski, Lukasz [2 ]
Wysokinska, Ewa [5 ]
机构
[1] Med Univ Warsaw, Univ Clin Ctr, Dept Oncol, PL-02091 Warsaw, Poland
[2] Polish Acad Sci, Inst Genet & Anim Biotechnol, Dept Mol Biol, PL-01447 Magdalenka, Poland
[3] Med Univ Warsaw, Univ Clin Ctr, PL-02091 Warsaw, Poland
[4] Med Univ Warsaw, Univ Clin Ctr, Dept Clin Radiol 2, PL-02091 Warsaw, Poland
[5] Mayo Clin, Div Hematol & Med Oncol, Jacksonville, FL 32224 USA
关键词
hepatocellular carcinoma; HCC; thrombocytopenia; platelets; outcome; tumor features; ENDOTHELIAL GROWTH-FACTOR; FACTOR-RECEPTOR-ALPHA; PLATELET COUNT; RADIOFREQUENCY ABLATION; PROGNOSTIC-FACTOR; POOR-PROGNOSIS; HEPATITIS-B; CANCER; RESECTION; SIZE;
D O I
10.3390/cancers16071293
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary: Currently, hepatocellular carcinoma (HCC) is one of the most prevalent oncological diagnoses worldwide. Despite intensive research into its pathogenesis and clinical course, numerous issues remain unresolved. In the presented meta-analysis and systematic review, we investigate the potential of blood platelet levels in patients with HCC for prognostic assessment. Blood platelets may play a significant role as an easily measurable laboratory parameter in assessing the prognosis of patients with HCC. Background: Platelets (PLT) have a role in the pathogenesis, progression, and prognosis of hepatocellular carcinoma (HCC) and could represent a readily measurable laboratory parameter to enhance the comprehensive evaluation of HCC patients. Methods: The PubMed, Web of Science, and Scopus databases were searched with a focus on survival as well as patient and tumor-specific characteristics in correlation to reported PLT counts. Survival outcomes were analyzed with both common-effect and random-effects models. The hazard ratio (HR) and its 95% confidence interval (CI) from analyzed trials were incorporated. Studies that did not provide survival data but focused on platelet count correlation with HCC characteristics were reviewed. Results: In total, 26 studies, including a total of 9403 patients, met our criteria. The results showed that thrombocytopenia in HCC patients was associated with poor overall survival (common-effect HR = 1.15, 95% CI: 1.06-1.25; random-effect HR = 1.30, 95% CI: 1.05-1.63). Moreover, three studies reveal significant correlations between PLT indices and tumor characteristics such as size, foci number, and etiology of HCC development. Conclusion: Our meta-analysis confirmed that PLT count could act as a prognostic marker in HCC, especially with a PLT count cut off <100 x 10(3)/mm(3). Further prospective studies focusing on the role of PLT in clearly defined subgroups are necessary.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] RACIAL AND ETHNIC DISPARITIES IN SURVIVAL AMONG PATIENTS WITH HEPATOCELLULAR CARCINOMA IN THE UNITED STATES: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Rich, Nicole E.
    Carr, Christian
    Yopp, Adam
    Marrero, Jorge A.
    Singal, Amit G.
    GASTROENTEROLOGY, 2021, 160 (06) : S67 - S67
  • [22] Racial and Ethnic Disparities in Survival Among Patients With Hepatocellular Carcinoma in the United States: A Systematic Review and Meta-Analysis
    Rich, Nicole E.
    Carr, Christian
    Yopp, Adam C.
    Marrero, Jorge A.
    Singal, Amit G.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (02) : E267 - E288
  • [23] Survival of patients treated with sorafenib for hepatocellular carcinoma recurrence after liver transplantation: A systematic review and meta-analysis
    Mancuso, Andrea
    Mazzola, Alessandra
    Cabibbo, Giuseppe
    Perricone, Giovanni
    Enea, Marco
    Galvano, Antonio
    Zavaglia, Claudio
    Belli, Luca
    Camma, Calogero
    DIGESTIVE AND LIVER DISEASE, 2015, 47 (04) : 324 - 330
  • [24] Somatostatin analogues in advanced hepatocellular carcinoma: An updated systematic review and meta-analysis of randomized controlled trials
    Ji, Xi-Qing
    Ruan, Xin-Jian
    Chen, Hong
    Chen, Gang
    Li, Shi-Yong
    Yu, Bo
    MEDICAL SCIENCE MONITOR, 2011, 17 (08): : RA169 - RA176
  • [25] Sarcomatoid hepatocellular carcinoma versus conventional hepatocellular carcinoma: a systematic review and meta-analysis
    Lv, Tian-Run
    Hu, Hai-Jie
    Regmi, Parbatraj
    Liu, Fei
    Li, Fu-Yu
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (07) : 1685 - 1696
  • [26] Sarcomatoid hepatocellular carcinoma versus conventional hepatocellular carcinoma: a systematic review and meta-analysis
    Tian-Run Lv
    Hai-Jie Hu
    Parbatraj Regmi
    Fei Liu
    Fu-Yu Li
    Journal of Cancer Research and Clinical Oncology, 2022, 148 : 1685 - 1696
  • [27] Exercise and colorectal cancer survival: an updated systematic review and meta-analysis
    Choy, Kay T.
    Lam, Kenneth
    Kong, Joseph C.
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2022, 37 (08) : 1751 - 1758
  • [28] Exercise and colorectal cancer survival: an updated systematic review and meta-analysis
    Kay T. Choy
    Kenneth Lam
    Joseph C. Kong
    International Journal of Colorectal Disease, 2022, 37 : 1751 - 1758
  • [29] Impact of pathological factors on survival in patients with upper tract urothelial carcinoma: a systematic review and meta-analysis
    Sharma, Gopal
    Yadav, Anuj Kumar
    Pareek, Tarun
    Kaundal, Pawan
    Tyagi, Shantanu
    Devana, Sudheer Kumar
    Singh, Shrawan Kumar
    INTERNATIONAL BRAZ J UROL, 2022, 48 (03): : 406 - 455
  • [30] Impact of Postoperative Complications on Long-Term Survival After Resection of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
    Junjie Kong
    Guangbing Li
    Jiawei Chai
    Guangsheng Yu
    Yong Liu
    Jun Liu
    Annals of Surgical Oncology, 2021, 28 : 8221 - 8233